What you need to know about the coronavirus right now – Reuters

What you need to know about the coronavirus right now – Reuters

Medical workers take swab samples from residents at a community nucleic acid testing centre for the coronavirus disease (COVID-19) at Sha Tin district, in Hong Kong, China, February 7, 2022. REUTERS/Lam Yik/File Photo
Feb 25 (Reuters) – Here’s what you need to know about the coronavirus right now:
Hong Kong infections spiral
Hong Kong has contracted a Chinese firm to build eight isolation and treatment facilities to help fight a worsening COVID-19 outbreak, as the government said on Friday daily cases in the global financial hub surged beyond 10,000 – a new record.
The temporary facilities, to be built by China State Construction International Holdings and with a combined capacity of 50,000 beds, will be spread across Hong Kong, including on private land lent for free by developers. read more
China sees highest imported cases in nearly 2 years
China on Friday reported the highest daily count of COVID-19 cases arriving from outside the mainland in nearly two years, with infections mostly from Hong Kong.
The mainland detected a total of 142 imported cases with confirmed symptoms on Thursday, the National Health Commission said on Friday. read more
Japan’s Shionogi seeks approval for COVID-19 pill
Drugmaker Shionogi & Co has applied for approval to make and sell its oral COVID-19 treatment in Japan, the firm said on Friday.
Known as S-217622, the drug would become the country’s third antiviral pill approved for coronavirus patients, following those developed by Pfizer and Merck. read more
Canada approves Medicago’s plant-based vaccine for adults
Medicago’s vaccine on Thursday became the world’s first plant-based shot approved against COVID-19 after Health Canada cleared it for use in adults.
The two-dose vaccine, which uses an adjuvant from GlaxoSmithKline to boost immune response, is the sixth COVID-19 shot to receive regulatory clearance in the country. read more
EMA backs Pfizer booster for teens, Moderna shot for ages 6-11
The European Union’s health regulator on Thursday backed giving a booster shot of Pfizer and BioNTech’s COVID-19 vaccine to adolescents aged 12 and over, as well as the expanded use of Moderna’s shot in children aged six to 11.
The recommendations by the European Medicine Agency’s Committee for Medicinal Products for Human Use will be followed by final decisions by the European Commission. read more
Commission finds Sweden should have clamped down harder
Sweden should have adopted tougher early measures as COVID-19 hit, though its mostly voluntary strategy was broadly correct, a commission reviewing the pandemic response said on Friday.
Sweden polarized opinion at home and abroad with its handling of the pandemic, opting against the lockdowns imposed by many countries and adopting a largely voluntary approach of promoting social distancing and good hygiene. read more
Our Standards: The Thomson Reuters Trust Principles.
Sign up to our health newsletter to keep up with the latest healthcare trends and pharmaceutical news.
Subscribe to our newsletter to get all the news you need to start your day.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world’s media organizations, industry events and directly to consumers.
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.
Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2022 Reuters. All rights reserved

source


Leave a Reply

Your email address will not be published.